Nutex Health Inc. Common Stock (NUTX) is a publicly traded Healthcare sector company. As of November 5, 2026, NUTX trades at $188.50 with a market cap of $1.41B and a P/E ratio of 19.96. NUTX moved -6.79% today. Year to date, NUTX is +15.39%; over the trailing twelve months it is +47.31%. Its 52-week range spans $45.88 to $226.16. Analyst consensus is strong buy with an average price target of $295.40. Rallies surfaces NUTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NUTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $188.50 |
| Market Cap | $1.41B |
| P/E Ratio | 19.96 |
| EPS | $11.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $226.16 |
| 52-Week Low | $45.88 |
| Volume | 134.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $875.26M |
| Net Income | $180.36M |
| Gross Margin | 50.76% |
5 analysts cover NUTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $295.40.